Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized Study Using N-Acetylcysteine as Prophylaxis of Sinusoidal Obstruction Syndrome in Patients Undergoing Hematopoietic Stem Cell Transplantation

NCT04712435 is registered in ClinicalTrials.gov with Instituto Brasileiro de Controle do Cancer as lead sponsor.

NCT NCT04712435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04712435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized Study Using N-Acetylcysteine as Prophylaxis of Sinusoidal Obstruction Syndrome in Patients Undergoing Hematopoietic Stem Cell Transplantation
Lead sponsor
Instituto Brasileiro de Controle do Cancer
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2021
Completion date
March 31, 2023
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic stem cell transplant (hsct), sinusoidal obstruction syndrome (sos)